Byetta (exenatide)

pCPA File Number: 20868

Negotiation Status:

Concluded without agreement

Indication(s):

Diabetes Mellitus, Type 2

Sponsor/Manufacturer:

AstraZeneca Canada Inc.

CDA-AMC Project Number:

SR0246-000

pCPA Engagement Letter Issued:

2012-06-01

Negotiation Process Concluded:

2013-06-13